Myeloproliferative Neoplasms Clinical Trials 201
April 2022
Clinical trials play a vital role in moving treatment and research advances forward. The Clinical Trials 201 program tackles common misconceptions and provides clear, actionable information about trials, sharing tools and resources for patients with essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF) who are considering clinical trial participation.
Program topics include:
Personalize Your Experience!
Create an account to save items and receive information curated just for you.
Understanding MPN Clinical Trial Terminology
The Benefits of MPN Clinical Trials
MPN Clinical Trial Safety
MPN Clinical Trial 201 Resources
[ACT]IVATED MPN program is brought to you by the Patient Empowerment Network. It is made possible through support from AbbVie, Inc. and generous donations from people like you.
